Company / Interest Expense
Collegium Pharmaceutical, Inc. Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$83.3M
FY2023
5-year range
$21.0M / $83.3M
FY2019-FY2023
Trend
+31.8%
vs FY2022
Sector context
#11 of 46
Health Care
What the data says
Collegium Pharmaceutical, Inc.'s interest expense of $83M is higher than 76% of companies in the Health Care sector (FY2023). Interest Expense has fluctuated over the past 7 years, ranging from $94,000 in FY2016 to $83M in FY2023.
Based on SEC 10-K filings.
$83M in FY2023 with a 5-year CAGR of +32.9%. Top quartile in the Health Care sector.
Increased from $21M to $83M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +42.4%
- 5-Year CAGR
- +32.9%
- 10-Year CAGR
- -
Sector benchmark
-70.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +32.9%, indicating consistent growth.
- In FY2023, interest expense increased 31.8% year-over-year.
- Ranks #11 out of 46 companies in the Health Care sector.
- Lowest interest expense in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $83.3M | +31.8% |
| FY2022 | $63.2M | +200.8% |
| FY2021 | $21.0M | -27.2% |
| FY2020 | $28.9M | +3077.3% |
| FY2019 | $909.0K | -95.5% |
| FY2018 | $20.1M | - |
| FY2017 | - | - |
| FY2016 | $94.0K | -78.6% |
As of FY2023 · SEC 10-K · Updated Jul 2, 2026